Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 9Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 4Prostatic Neoplasms 3Barrett Esophagus 3Stomach Neoplasms 2Recurrence 2Rectal Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Multiple Pulmonary Nodules 2Melanoma 2Glioma 2Colorectal Neoplasms 2Adenocarcinoma of Lung 2Triple Negative Breast Neoplasms 1Thyroid Nodule 1Thyroid Neoplasms 1Spinal Fractures 1Solitary Pulmonary Nodule 1Smoking Cessation 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Phyllodes Tumor 1Osteoporosis 1Nevus 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Lymphoma, Follicular 1Lung Diseases 1

Interventions

pembrolizumab 163Carboplatin 146Paclitaxel 125Cyclophosphamide 94130-nm albumin-bound paclitaxel 66Capecitabine 64Gemcitabine 54Doxorubicin 50Albumin-Bound Paclitaxel 45Taxes 42atezolizumab 41Cisplatin 39sacituzumab govitecan 34Nivolumab 34olaparib 32Epirubicin 32Specimen Handling 28Docetaxel 28eribulin 27Bevacizumab 26durvalumab 25Drug Therapy 25Biopsy 24camrelizumab 23Magnetic Resonance Spectroscopy 22toripalimab 19Radiotherapy 17spartalizumab 16Everolimus 15veliparib 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Triple Negative Breast Neoplasms × Diagnostic Imaging × Clear all
NCT05035407 2025-12-02

T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
36 enrolled 7 charts
Breast

Carcinoma, Neoplasm Metastasis, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡